Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline Wins Another FDA ‘Breakthrough’ Designation
GlaxoSmithKline Wins Another FDA ‘Breakthrough’ Designation
GlaxoSmithKline Wins Another FDA ‘Breakthrough’ Designation
Submitted by
admin
on February 3, 2014 - 3:56pm
Source:
Wall St Cheat Sheet
News Tags:
GSK
FDA
breakthrough therapies
severe aplastic anemia
Promacta
Revolade
Headline:
GlaxoSmithKline Wins Another FDA ‘Breakthrough’ Designation
Do Not Allow Advertisers to Use My Personal information